Roche CFO Says Co. Commited to Genentech (DNA) Deal -Reuters
Reuters is reporting that Roche's (OTC: RHHBY) CFO, Erich Hunziker, has made comments saying that Roche is committed to the Genentech (NYSE: DNA) transaction.
Genentech, Inc. engages in the discovery, development, manufacture, and commercialization of pharmaceutical products in the United States.
Related Categories
Corporate NewsMergers and Acquisitions
Trader Talk
Stocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
